Claims for Patent: 11,253,472

Summary for Patent: 11,253,472

Title:	Oral cannabinoid formulations
Abstract:	Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.
Inventor(s):	Goskonda; Venkat R. (Phoenix, AZ), Chavan; Ashok (Chandler, AZ), Kokate; Amit (Englewood, NJ), Gill; Howard (Scottsdale, AZ)
Assignee:	Benuvia Therapeutics LLC (Chandler, AZ)
Application Number:	16/282,817
Patent Claims:	1. A stable oral pharmaceutical solution comprising from about 0.1% to about 5% w/w of dronabinol, 31.90% w/w or less water, from about 15% to about 90% w/w alcohol and from about 17.5% w/w of a co-solvent consisting of propylene glycol, polyethylene glycol or a mixture thereof and an antioxidant, wherein w/w denotes weight by total weight of the solution and wherein the pharmaceutical formulation solution is an oral solution. 2. The solution of claim 1, wherein the alcohol is at a concentration from about 40% to about 90% w/w. 3. The solution of claim 1, wherein the alcohol is at a concentration from about 15% to about 65% w/w.